He H - Search Results

1

Elevated expression of IMPDH2 is associated with progression of kidney and bladder cancer.

Zou J, Han Z, Zhou L, Cai C, Luo H, Huang Y, Liang Y, He H, Jiang F, Wang C, Zhong W. Zou J, et al. Among authors: he h. Med Oncol. 2015 Jan;32(1):373. doi: 10.1007/s12032-014-0373-1. Epub 2014 Dec 3. Med Oncol. 2015. PMID: 25465060

2

[Effects of potassium citrate delayed preparation in urine PH and citric acid content].

He HC, Zhong WD, Xie KJ, Dai QS, Zeng GQ, Wei H, Wei HA, Mei H. He HC, et al. Zhonghua Yi Xue Za Zhi. 2004 Nov 2;84(21):1825-6. Zhonghua Yi Xue Za Zhi. 2004. PMID: 15631783 Clinical Trial. Chinese. No abstract available.

3

cDNA macroarray for analysis of gene expression profiles in prostate cancer.

Zhong WD, He HC, Bi XC, Ou RB, Jiang SA, Liu LS. Zhong WD, et al. Chin Med J (Engl). 2006 Apr 5;119(7):570-3. Chin Med J (Engl). 2006. PMID: 16620698

4

Detection of pim-1 mRNA in prostate cancer diagnosis.

He HC, Bi XC, Dai QS, Wang SS, Wei HA, Zhong WD, Liu WH, Jiang FN, Liu LS. He HC, et al. Chin Med J (Engl). 2007 Sep 5;120(17):1491-3. Chin Med J (Engl). 2007. PMID: 17908456

5

[Early diagnosis of bladder cancer by special fluorescence spectrum: an in vitro experiment].

Zou J, He HC, Yao YB, Dai QS, Han ZD, Zhong WD. Zou J, et al. Zhonghua Yi Xue Za Zhi. 2007 Sep 25;87(36):2544-6. Zhonghua Yi Xue Za Zhi. 2007. PMID: 18067829 Chinese.

6

Ki-67 and PCNA expression in prostate cancer and benign prostatic hyperplasia.

Zhong W, Peng J, He H, Wu D, Han Z, Bi X, Dai Q. Zhong W, et al. Among authors: he h. Clin Invest Med. 2008;31(1):E8-E15. doi: 10.25011/cim.v31i1.3136. Clin Invest Med. 2008. PMID: 18312749

7

Protective effect of ganoderan on renal damage in rats with chronic glomerulonephritis.

Zhong WD, He HC, Ou RB, Bi XC, Dai QS, Han ZD, Liang YX, Ye YK, Qin WJ, Li Z, Zeng GH, Zhu G. Zhong WD, et al. Clin Invest Med. 2008;31(4):E212-7. doi: 10.25011/cim.v31i4.4782. Clin Invest Med. 2008. PMID: 18682045

8

CD147, MMP-1, MMP-2 and MMP-9 protein expression as significant prognostic factors in human prostate cancer.

Zhong WD, Han ZD, He HC, Bi XC, Dai QS, Zhu G, Ye YK, Liang YX, Qin WJ, Zhang Z, Zeng GH, Chen ZN. Zhong WD, et al. Oncology. 2008;75(3-4):230-6. doi: 10.1159/000163852. Epub 2008 Oct 14. Oncology. 2008. PMID: 18852494

9

Real-time quantitative RT-PCR assessment of PIM-1 and hK2 mRNA expression in benign prostate hyperplasia and prostate cancer.

He HC, Bi XC, Zheng ZW, Dai QS, Han ZD, Liang YX, Ye YK, Zeng GH, Zhu G, Zhong WD. He HC, et al. Med Oncol. 2009;26(3):303-8. doi: 10.1007/s12032-008-9120-9. Epub 2008 Nov 12. Med Oncol. 2009. PMID: 19003546

10

CD147 expression indicates unfavourable prognosis in prostate cancer.

Han ZD, Bi XC, Qin WJ, He HC, Dai QS, Zou J, Ye YK, Liang YX, Zeng GH, Chen ZN, Zhong WD. Han ZD, et al. Pathol Oncol Res. 2009 Sep;15(3):369-74. doi: 10.1007/s12253-008-9131-z. Pathol Oncol Res. 2009. PMID: 19048397 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16,178 results

Search Page

Filters